Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Biomedical Optics|April 7, 2004
Birefringence measurements in human skin using polarization-sensitive optical coherence tomographyMark C Pierce, John Strasswimmer, B Hyle Park, et al.Journal of Biomedical Optics|April 7, 2004
Polarization-sensitive optical coherence tomography of invasive basal cell carcinomaJohn Strasswimmer, Mark C Pierce, B Hyle Park, et al.Brachytherapy|August 31, 2015
Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group reportZoubir Ouhib, Michael Kasper, Jose Perez Calatayud, et al.Dermatology Online Journal|September 17, 2020
Hand-foot skin reaction with primarily dorsal involvement in a patient with metastatic renal cell carcinoma on cabozantinibAmrita Goyal, Audrey A Jacobsen, Daniel O'Leary, et al.Journal of Cutaneous Pathology|June 21, 2017
Nodular cutaneous amyloidoma of the extremity secondary to chronic granulomatous inflammation in setting of sarcoidosisVictoria L Billero, Audrey A Jacobsen, Mariya I Miteva, et al.Blood Cells, Molecules & Diseases|December 5, 2021
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosisRoy L Kao, Audrey A Jacobsen, Charles J Billington, et al.Cureus|May 6, 2024
Knowledge, Attitudes, and Perceptions of Skin Cancer Clinical Trials in the Hispanic PopulationLuis F Andrade, Maria J Lalama, Siri Choragudi, et al.Brachytherapy|May 16, 2020
The American Brachytherapy society consensus statement for skin brachytherapyChirag Shah, Zoubir Ouhib, Mitchell Kamrava, et al.Future Oncology (London, England)|January 11, 2025
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinomaSoo J Park, David M Ellison, Ryan Weight, et al.Journal of the American Academy of Dermatology|August 22, 2025
Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III studyTodd Schlesinger, M Shane Chapman, John H Tu, et al.Pageof 3